Menu Back to 11th-Annual-Forum-for-Qualified-Persons-in-Pharmacovigilance

Overview

This is so much more than a meeting. It’s a community.

See what the community has to share about what makes this conference unique. Read the Testimonials.

The only event developed by QPPVs for QPPVs, now in its 11th year, the network at the QPPV Forum continues to grow. This year’s forum objectives build on past successes and have been shaped by valuable feedback provided by participants of the past ten meetings.

What can you expect by joining this community in 2017?

  1. Build relationships with fellow QPPVs
  2. Reconnect with colleagues and meet regulators
  3. Hear the latest updates and hot topics relating to the role of the QPPV
  4. Explore long term PV visions, future directions of the ‘PV world’, and potential impact on the role of QPPV
  5. Learn from and share experience and ideas with like-minded QPPVs in a neutral environment
  6. Better understand regulatory and inspectorate expectations of the QPPV
  7. Identify the expanded expectations of the role in the context of the new regulatory framework and transparency initiatives

Over time, one of the key successes of the Forum has been the ability to secure continuing support and involvement of key regulators. Sessions have been open and interactive with attendees appreciating opportunities to raise challenging issues in an informal environment. This QPPV Forum aims to continue to attract such key speakers and encourage open debate.

HIGHLIGHTS - NETWORKING DINNER

The Networking (Buffet) Dinner will start at 18:30h at the:
Crowne Plaza London - Docklands
Royal Victoria Dock
Western Gateway
London, E16 1AL
T: + 44-20-70552000
Dress code: business casual

Download Programme

Who should attend?

  • EU QPPVs and Deputies (present or aspiring), regardless of company size
  • Pharmacovigilance Regulators and Inspectors
  • CRO and Consultants providing QPPV Services
  • National Responsible Persons for Pharmacovigilance
  • Quality Management Personnel
  • Heads of Pharmacovigilance
  • Other stakeholders supporting the EU QPPV

Program Committee

  • Peter  De Veene, MD
    Peter De Veene, MD Head Global Drug Safety & QPPV
    Grunenthal Gmbh, Germany
  • Elspeth  McIntosh
    Elspeth McIntosh Director
    Castle Pharmacovigilance Ltd, United Kingdom
  • Margaret Anne Walters
    Margaret Anne Walters Director & Deputy EU Qualified Person for Pharmacovigilance
    Merck, Sharp & Dohme Ltd, United Kingdom
  • Michael  Richardson, MD, FFPM
    Michael Richardson, MD, FFPM International GPV&E and EU QPPV
    Bristol-Myers Squibb, United Kingdom
  • Brian David Edwards, DrMed
    Brian David Edwards, DrMed Principal Consultant, Pharmacovigilance and Drug Safety, Vice-President ACRES
    NDA Regulatory Science Ltd., United Kingdom
  • Barbara  De Bernardi, MD
    Barbara De Bernardi, MD Deputy EU QPPV and European Safety Office Head
    Pfizer Italia S.r.l., Italy
  • Vicki  Edwards, RPh
    Vicki Edwards, RPh Vice President, Pharmacovigilance Excellence and QPPV
    AbbVie, Inc., United Kingdom
  • Winrich  Rauschning, DrMed, MD, MBA
    Winrich Rauschning, DrMed, MD, MBA QPPV
    Biolitec Pharma, Germany
  • Doris Irene Stenver, MD, MPA
    Doris Irene Stenver, MD, MPA Chief Medical Officer
    Danish Medicines Agency, Denmark
Load More

Contact us

Registration Questions

Send Email
+41 61 225 51 51


Agenda and Logistics

Send Email
+41 61 225 51 49


Advertising Opportunities

Send Email
+41 61 225 51 51
Download Prospectus

Digital Learning Catalog

eLearning Catalog Cover
Download